Company Profile
Tempest Therapeutics Stock Price, News & Analysis
Company overview
Business overview
Tempest Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Tempest Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Tempest Therapeutics follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Tempest Therapeutics sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Why the stock is moving
TPST is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Future catalysts
Tempest's story has shifted toward TPST-2003 and the newly acquired dual-targeting CAR-T assets. The REDEEM-1 interim data in relapsed and refractory multiple myeloma is the main item, and the company now has to prove that the new portfolio can turn that early signal into something more durable.
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Tempest Announces Closing of Strategic Acquisition of Dual-Targeting CAR-T Assets
Source: Tempest Therapeutics
- 02
Tempest Lays Out Strategic Plan to Advance Recently Acquired Dual-Targeting CAR-T Assets
Source: Tempest Therapeutics
- 03
- 04
Tempest Announces Partnership for TPST-2003 in Preparation for Planned U.S. Registrational Study in 2026
Source: Tempest Therapeutics
- 05
Tempest Therapeutics Announces Up To $6 Million Private Placement
Source: Tempest Therapeutics
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.